Advanced Medical Solutions Group (LON:AMS) Stock Price Passes Below 200-Day Moving Average – Should You Sell?

Advanced Medical Solutions Group plc (LON:AMS)’s stock price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 218.61 ($2.84) and traded as low as GBX 188.80 ($2.45). Advanced Medical Solutions Group shares last traded at GBX 197 ($2.55), with a volume of 557,270 shares trading hands.

Analysts Set New Price Targets

Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 300 ($3.89) price objective on shares of Advanced Medical Solutions Group in a research note on Wednesday, September 18th.

Advanced Medical Solutions Group Trading Up 2.7 %

The company has a market cap of £422.66 million, a PE ratio of 3,940.00, a PEG ratio of 5.00 and a beta of 0.74. The stock has a fifty day moving average of GBX 226.88 and a 200-day moving average of GBX 218.61. The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39.

Advanced Medical Solutions Group Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, October 25th. Shareholders of record on Thursday, September 26th were issued a GBX 0.77 ($0.01) dividend. This represents a dividend yield of 0.32%. The ex-dividend date was Thursday, September 26th. Advanced Medical Solutions Group’s dividend payout ratio is 4,000.00%.

Insiders Place Their Bets

In other news, insider Grahame Cook bought 48,864 shares of the stock in a transaction on Thursday, October 10th. The stock was acquired at an average cost of GBX 205 ($2.66) per share, for a total transaction of £100,171.20 ($129,906.89). Company insiders own 3.12% of the company’s stock.

About Advanced Medical Solutions Group

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare.